Pricing Log in Create free account

Passage Bio, Inc. (PASG) vs Tvardi Therapeutics, Inc. (TVRD)

Passage Bio, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Passage Bio, Inc. and Tvardi Therapeutics, Inc. are of similar size ($11.5M and $11.1M). Across the 9 metrics below, Tvardi Therapeutics, Inc. leads on 6 and Passage Bio, Inc. on 3.

Valuation

Metric PASG TVRD Biotechnology median
P/E n/m n/m 10.26
P/S n/m 1.05 9.18
P/B 2.48 0.95 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.34 n/m 0.65
EV/Sales n/m 6.83 8.98
Earnings yield (329.07%) (328.24%) (34.89%)
Free cash flow yield (330.47%) (353.24%) (24.52%)

Profitability

Metric PASG TVRD Biotechnology median
Gross margin 0.00% 146.85% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (169.09%) (126.19%) (50.12%)
Return on assets (69.20%) (85.08%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PASG TVRD Biotechnology median
Revenue growth (TTM) — (55.30%) 6.26%
EPS growth (last fiscal year) 32.94% 71.45% 29.88%
Revenue growth, 5-year CAGR — (18.53%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PASG TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.22 1.87 4.89
Net debt to EBITDA 0.96 1.15 1.01

Dividend

Metric PASG TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PASG TVRD Biotechnology median
Market cap 11.13m 11.53m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack